Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Sponsor: University Hospital, Toulouse
Summary
The aim of this study is to discover the immune and oncogenomic features that distinguish patients who respond to teclistamab from patients who are primarily resistant. Moreover, phenotypic and genotypic characteristics that occur with secondary resistance to teclistamab will be analyzed.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-09-28
Completion Date
2026-05-31
Last Updated
2025-04-10
Healthy Volunteers
No
Conditions
Interventions
Bone marrow sampling
Bone marrow sampling collected at 12 weeks after initiation treatment (day 1 cycle 4)
Locations (18)
CHU d'Amiens
Amiens, France, France
CHU de Caen
Caen, France, France
Polyclinique du Parc Drevon
Dijon, France, France
CH Annecy Genevois
Epagny Metz- Tessy, France, France
CHU de Lille
Lille, France, France
Centre Léon Bérard
Lyon, France, France
CHU de Montpellier
Montpellier, France, France
Hôpital Saint-Louis
Paris, France, France
Hôpital Saint-Antoine
Paris, France, France
Hôpital Necker
Paris, France, France
CHU de Bordeaux
Pessac, France, France
CHU de Lyon
Pierre-Bénite, France, France
CHU de Poitiers
Poitiers, France, France
CHU de Rennes
Rennes, France, France
CH Saint-Etienne
Saint-Priest-en-Jarez, France, France
CHU de Toulouse
Toulouse, France, France
CHU de Tours
Tours, France, France
CHRU Nancy
Vandœuvre-lès-Nancy, France, France